Acesion Pharma changes CEO, prepares for investment and aims for IPO Danish biotech firm Acesion Pharma is going through changes. The company is looking for a new CEO, expects to raise a three-digit million sum soon and aims to go public in two years. Frans Wuite leaves Acesion Pharma after four years as CEO. He will continue as a consultant for the next six months. Photo: Acesion Pharma / PR BY KEVIN GRØNNEMANN, TRANSLATED BY IDA LØJMAND Published: 29.07.20 at 16:51 Share by email Share on LinkedIn Share on Facebook Share on Twitter Log in to read our articles Welcome to MedWatch. A part of our content is exclusive and reserved for our users. Log in Try MedWatch for 14 days. Get a trial subscription here. Do you want a trial subscription with multiple users for yourself and your colleagues? Read more about your options and find the contact information to our sales team here. Print Print Increase text size Increase text size Decrease text size Decrease text size Related articles Entrepreneurs criticize universities' startup assistance: "The system doesn't work"